Need Help?
Click here and start chatting with us!
The North America Long Read Sequencing Market has demonstrated significant revenue growth from 2020 through 2025, with an upswing from 485 Million USD in 2020 to an estimated 1,192 Million USD in 2025. Projected forecasts highlight further acceleration, reaching approximately 4,980 Million USD by 2035. Growth is attributed to technological innovations, broadening clinical applications, and increased research funding. The upward trajectory reflects expanding adoption beyond academic research into mainstream diagnostics and personalized healthcare.
Read More - https://bussinessinsights.com/research-report/north-america-long-read-sequencing-market
De Novo sequencing accounts for the highest proportion of applications in the North America market, as it remains vital for assembling new genomes without reference data. Cancer genomics is witnessing rapid growth, reflecting the demand for precision oncology solutions and actionable insights from complex cancer genomes. Variant detection continues to be crucial, especially in hereditary disease research and clinical diagnostics, ensuring comprehensive genomic understanding.
Request Free Sample- https://bussinessinsights.com/request/healthcare/north-america-long-read-sequencing-market
Who are the key players in North America Long Read Sequencing Market industry?
Key players include Pacific Biosciences, which is renowned for its SMRT sequencing technology; Oxford Nanopore Technologies, a leader in nanopore-based sequencing; Illumina, an innovator in genomics; Agilent Technologies, providing sequencing solutions; and BGI Genomics, a significant contributor to genomic research and sequencing platforms.
What is the North America Long Read Sequencing Market growth?
The North America Long Read Sequencing Market has experienced robust growth, driven by increasing adoption in genomic research. In 2023, Pacific Biosciences announced significant revenue growth, fueled by rising demand for high-throughput and accurate sequencing needed in clinical diagnostics and genetic research.
Which segment accounted for the largest North America Long Read Sequencing Market share?
The human genomics and clinical research application segment captured the largest market share. The widespread use of long read sequencing to identify genetic disorders, improve disease diagnosis, and advance personalized medicine has driven adoption among research institutes and healthcare organizations across North America.
Thanks & Regards,
Manisha C
sales [at] bussinessinsights.com